PRC
ASXC

Pearl River Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

Pearl River Capital’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-131
Closed -$4K – 860
2018
Q4 		$4K Buy
+131
New +$5.95K 0.02% 753

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pearl River Capital's ASXC Position: Q1 2019 in Review

Pearl River Capital sold out of Asensus Surgical, Inc. (ASXC) in Q1 2019, closing a stake of 131 shares — an estimated $4K sold.

Pearl River Capital first reported a position in ASXC in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 149 funds tracked by Wall St. Rank hold ASXC as of Q1 2019.

  • Pearl River Capital reported no remaining Asensus Surgical, Inc. position as of Q1 2019 after selling out during the quarter.
  • Pearl River Capital sold 131 Asensus Surgical, Inc. shares in Q1 2019, an estimated $4K.
  • Pearl River Capital first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 1 quarter.
  • Pearl River Capital's Asensus Surgical, Inc. position peaked at $4K in Q4 2018.
  • 149 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.